Master Pharma, also known as Master Pharmaceuticals, is a leading player in the pharmaceutical industry, headquartered in the United States. Founded in 2004, the company has established a strong presence in key operational regions, focusing on the development and distribution of high-quality pharmaceutical products. Specialising in generic and branded medications, Master Pharma is recognised for its commitment to innovation and quality assurance. The company’s core offerings include a diverse range of prescription medications, which are distinguished by their efficacy and affordability. With a robust market position, Master Pharma has achieved significant milestones, including numerous partnerships and expansions that underscore its reputation for excellence in the pharmaceutical sector. As a trusted name in healthcare, Master Pharma continues to enhance patient outcomes through its dedicated approach to pharmaceutical solutions.
How does Master Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Master Pharma's score of 10 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Master Pharma, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprint across various scopes of emissions. As Master Pharma continues to navigate its environmental responsibilities, it may consider establishing measurable climate commitments to align with industry standards and contribute to global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Master Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.